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Regional Metabolite Concentrations in Human Brain as 
Determined by Quantitative Localized Proton MRS 
Petra J. W. Pouwels, Tens Frahm 
The regional distribution of brain metabolites was studied in 
several cortical white and gray matter areas, cerebellum, and 
thalamus of young adults with use of quantitative single-voxel 
proton MRS at 2.0 T. Whereas the neuronal compound N- 
acetylaspartate is distributed homogeneously throughout the 
brain, N-acetylaspartylglutamate increases caudally and ex- 
hibits higher concentrations in white matter than in gray mat- 
ter. Creatine, myo-inositol, glutamate, and glutamine are less 
concentrated in cortical white matter than in gray matter. The 
highest creatine levels are found in cerebellum, parallel to the 
distribution of creatine kinase and energy-requiring pro- 
cesses in the brain. Also myo-inositol has highest concentra- 
tions in the cerebellum. Choline-containing compounds ex- 
hibit a marked regional variability with again highest 
concentrations in cerebellum and lowest levels and a strong 
caudally decreasing gradient in gray matter. The present find- 
ings neither support a metabolic gender difference (except for 
a 1.3-fold higher myo-inositol level in parietal white matter of 
female subjects) nor a metabolic hemispheric asymmetry. 
Key words: proton spectroscopy; brain metabolism; cerebral 
metabolite distribution. 
INTRODUCTION 
Quantification of absolute metabolite concentrations in 
human brain is required not only for a better understand- 
ing of in vivo neurochemistry but also for an unambigu- 
ous assessment of pathologic alterations and pertinent 
applications in clinical diagnosis and therapy monitor- 
ing. Initial emphasis of localized proton MRS studies has 
been placed on the evaluation of metabolite patterns 
specific for tissue types such as gray and white matter 
(1-4). However, because both gray and white matter ex- 
tend over large cortical and subcortical areas with dis- 
tinct anatomic and functional properties, more detailed 
differences are likely to be expected. This hypothesis has 
been supported by a preliminary short-echo time proton 
MRS study of cortical gray matter (5). Pertinent findings 
are in line with earlier MRS reports on regional metabolic 
heterogeneity although such studies were often compro- 
mised by the use of mixed tissue volumes, long echo 
times, and/or ratios of resonance intensities or concen- 
trations (6-10). 
The primary aim of the present work therefore was a 
reliable and detailed determination of absolute metabo- 
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lite concentrations in multiple locations of cortical and 
subcortical gray and white matter. In addition, the data 
were analyzed for putative gender differences and hemi- 
spheric asymmetry. 
METHODS 
Studies of 34 healthy volunteers (17 female/l7 male, age 
range 18-39 years, mean 27 5 4 years) were conducted at 
2.0 T (Siemens Magnetom SP4000, Erlangen) using the 
standard imaging headcoil. Informed written consent 
was obtained before all examinations. A total of 41 stud- 
ies were performed yielding about five spectra each. 
Figure 1 shows representative volumes-of-interest 
(VOI) selected for localized proton MRS. Cortical white 
matter was measured in frontal, parietal, and occipital 
brain (Fig. l a )  with small volumes of 4.1-6.4 ml to pre- 
vent contamination with gray matter. Gray matter vol- 
umes in frontal (8-12 ml), parietal (8-18 ml), and occip- 
ital brain (8 ml) were located in paramedian positions 
spanning 20 mm across the interhemispheric fissure (Fig. 
1b). In addition, gray matter was investigated in insular 
areas (10 ml) and thalamus (6.4 ml) (Fig. 1c). The cere- 
bellum (8 ml) was examined both in a central position 
covering the vermis (Fig. Ib) and in hemispheric loca- 
tions containing mainly white matter (Fig. Id). 
Fully relaxed, short-echo time proton MR spectra were 
recorded with use of a single-voxel STEAM localization 
sequence (TR/TE/TM = 6000/20/30 ms, 64 accumula- 
tions) as described previously (11). Particular care was 
taken to optimize magnetic field homogeneity and water 
suppression by localized adjustments. Spectroscopic 
time-domain data were corrected for residual eddy cur- 
rent effects (12) and calibrated in proportion to the actual 
coil loading by using the transmitter reference amplitude 
(3).  For display purposes only, spectral postprocessing 
involved zero-filling to 4K complex data points (2048 
ms), Gaussian filtering (half-width 317 ms), and manual 
phase-correction. Such spectra were not used for quanti- 
fication. 
Absolute metabolite concentrations were estimated by 
LCModel, a user-independent fitting routine that em- 
ploys a library of concentration-calibrated model spectra 
of all individual metabolites (3, 13). The method exploits 
the full spectroscopic information of each metabolite and 
not just isolated intense resonances. It therefore allows a 
distinction even between metabolites with overlapping 
signals provided they exhibit additional proton reso- 
nances at different frequencies. Because the separation of 
two overlapping metabolites also depends on the spectral 
resolution attainable in vivo, LCModel not only yields 
individual concentrations of such metabolites, but also 
offers a treatment as the sum of both. For example, total 
NAA (tNAA) is determined in addition to separate con- 
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FIG. 1. T,-weighted MR images (RF spoiled 3D FLASH, TRITE = 15/6 ms, flip angle 20’) showing 
representative locations selected for proton MRS of white matter in frontal, parietal, and occipital 
brain (a); gray matter in paramedian frontal, parietal, and occipital brain, as well as in the central 
cerebellum (b); gray matter in the insular area and in thalamus (c); and white matter in the cerebellar 
hemisphere (d). 
centrations of N-acetylaspartate (NAA) and N-acetylas- 
partylglutamate (NAAG) (14). Similarly, the amount of 
choline-containing compounds (Cho) is expressed as the 
sum of phosphorylcholine (PCh) and glycerophosphoryl- 
choline (GPC) as suggested by in vivo phosphorus MRS 
(15) and in vitro proton MRS (16, 17).  The need for 
including GPC in the library of model spectra was evi- 
denced by a discrepancy between experimental spectra 
and the corresponding LCModel fits, i.e., the appearance 
of a 3.68-ppm proton resonance in the residual “base- 
line,” when PCh was the only Cho-compound. Most 
likely, this resonance belongs to the methylene protons 
of the glycerol backbone of GPC. 
Macromolecules with short T2 relaxation times also 
contribute to short echo-time spectra (18, 19). However, 
the baseline estimated by LCModel includes resonances 
with broad linewidths. Thus, the quantitation of small, 
mobile metabolites is not affected by macromolecular 
contributions. In this study no attempt has been made to 
further characterize residual broad resonances. 
Concentrations are expressed as mmol/liter VOI (i.e., 
as mM) and are not corrected for CSF contributions and 
residual T2 relaxation effects. T,  saturation was ignored 
as all experiments were performed under fully relaxed 
conditions using sufficiently 
long repetition times TI?. Be- 
cause the model spectra were 
measured with similar param- 
eters as the in vivo spectra, 
only differences in T, relax- 
ation between in vivo and in 
vitro must be taken into ac- 
count. For Tz relaxation times 
between 130 and 370 ms in 
vivo and approximately 800 
ms in vitro correction factors 
range from 1.03 to 1.14 at an 
echo time of TE = 20 ms (3). 
However, because T,  relax- 
ation times of metabolites 
show a regional dependence 
(1, 4, 6, 7), such small correc- 
tions were ignored as they 
would be at the expense of 
time-consuming determina- 
tions of metabolite T, values 
in each VOI that are not toler- 
able for related MRS studies of 
patients. For similar reasons, 
data were not corrected for po- 
tential contributions from 
CSF. Pertinent correction fac- 
tors amount to about 1.05-1.07 
for gray matter of young 
healthy adults ( 3 ,  4), and even 
less for other regions. In pa- 
tient studies the observation of 
reduced metabolite concentra- 
tions may reflect brain atrophy 
due to larger CSF contribu- 
tions. In that case a compari- 
son with healthy controls ei- 
ther may be based on concentration ratios, or requires an 
estimation of the CSF contribution to the VOI, eg. ,  by 
using image segmentation. 
Statistical comparisons between regions were per- 
formed with two-sided unpaired t tests assuming un- 
equal variances. Gender differences were assessed by 
applying these tests to metabolite concentrations of fe- 
male and male subjects for each region separately. Data 
from hemispheric regions (cortical white matter, insular 
gray matter, cerebellar hemispheres, and thalamus) were 
further examined for right-left asymmetry, both intrain- 
dividually and interindividually. The intraindividual 
asymmetry parameter (individual laterality) was defined as 
the concentration ratio of a single metabolite in right versus 
left hemispheres for each subject with bilateral spectral 
acquisitions. The interindividual asymmetry (species later- 
ality) was assessed by comparing concentrations from right 
and left hemisphere of all subjects with a two-sided t test. 
RESULTS 
White Matter 
Representative proton MR spectra of frontal, parietal, and 
occipital white matter are shown in Fig. 2. The regional 
Regional Concentrations of Human Brain Metabolites 55 
WM frontal 
1 
4.0 3.5 3.0 2.5 2.0 1.5 1.0 
NAA WM parietal 
~ 
4.0 3.5 3.0 2.5 2.0 1.5 1.0 
WM occipital 
4.0 3.5 3.0 2.5 2.0 1.5 1.0 
Chemical Shift / ppm 
FIG. 2. Localized proton M R  spectra (STEAM, TR/TE/TM = 6000/ 
20/30 ms, 64 accumulations) of a 22-year-old subject in frontal 
(5.1 ml), parietal (6.4 ml), and occipital white matter (5.1 ml). Major 
metabolites refer to N-acetylaspartate (“I), N-acetylaspartylglu- 
tamate (NAAG), glutamate (Glu), glutamine (Gln), total creatine 
(Cr), choline-containing compounds (Cho), and myo-inositol (Ins). 
similarity is confirmed by an analysis of mean metabolite 
concentrations in white matter of all subjects summa- 
rized in Table 1. Creatine and phosphocreatine (Cr) as 
well as Cho are distributed uniformly throughout cortical 
white matter. In contrast, the concentration of tNAA is 
significantly lower in frontal white matter than in pari- 
etal or occipital white matter. Separation of NAA and 
NAAG shows that this distribution of tNAA is almost 
exclusively due to NAAG, whereas no significant re- 
gional differences are observed for NAA (14). Thus, the 
contribution of NAAG to tNAA varies from 15% in fron- 
tal white matter to 25% in parietal and occipital white 
matter. 
A regional dependence is also observed for myo-inosi- 
to1 (Ins). While this metabolite is equally distributed in 
periventricular white matter frontally and occipitally, its 
concentration in parietal white matter is significantly 
lower. Finally, no regional variations are revealed for 
glutamate (Glu) and glutamine (Gln). 
Gray Matter 
Gray matter spectra of frontal, parietal, and occipital 
brain, as well as of the insular area are shown in Fig. 3. 
The most striking observation is a gradient in Cho yield- 
ing an intensity decrease from frontal to occipital cortex. 
A quantitative analysis of all gray matter spectra in Table 
2 confirms highly significant differences in Cho concen- 
tration between frontal and parietal, as well as between 
parietal and occipital gray matter. When gray and white 
matter regions are compared, even the highest levels of 
Cho in frontal gray matter are lower than those found in 
white matter. 
The regional variability of tNAA, which has a higher 
concentration in occipital than in parietal or frontal gray 
matter, is due to enhanced levels of both NAA and NAAG 
in occipital cortex. Whereas the concentration of NAA in 
frontal and parietal gray matter is similar to that in white 
matter, it is significantly higher in occipital cortex. Be- 
tween and within white and gray matter, the largest 
variability is observed for NAAG, which has lower con- 
centrations in gray matter, but shows a caudal increase in 
both tissues (14). Cr, Ins, Glu, and Gln are distributed 
homogeneously throughout paramedian gray matter but 
at higher levels than in white matter. For all metabolites, 
concentrations in the insular area are higher than in 
parietal gray matter. Similar concentration ratios with 
respect to Cr suggest that this may partly be explained by 
reduced CSF contributions in insular areas versus para- 
median locations. 
Concentrations of other brain metabolites like scyllo- 
inositol, glucose, lactate, taurine, y-amino butyric acid, 
and aspartate are also determined by LCModel. However, 
unfavorable conditions such as considerable spectral 
overlap, strong coupling, and rather low concentrations 
usually prevent a reliable determination in individual 
subjects. On the other hand, group averages result in 
reasonable estimates of pertinent concentrations in pari- 
etal gray matter (n = 19) of 0.14 t 0.09 mM for scyllo- 
inositol, 0.5 5 0.6 mM for glucose, 0.6 5 0.4 mM for 
lactate, 1.0 2 0.4 mM for taurine, 1.4 t 0.8 mM for 
y-amino butyric acid, and 1.4 t 0.8 mM for aspartate. 
Table 1 
Metabolite Concentrations in White Matter (mM f SD)a 
Frontal Parietal Occipital 
n = 22 n = 20 n = 27 
Cr 5.7 f 0.5 5.7 f 0.6 5.5 IT 0.8 
tNAA 9.6 2 1.1** 10.6 t 0.8 10.4 f 0.9 
NAA 8.1 f 0.9 8.0 t 1.0 7.8 i 0.9 
NAAG 1.5 5 0.9**‘ 2.7 f 1.2 2.6 IT 1.0 
Cho 1.78 f 0.41 1.68 5 0.27 1.64 t 0.21 
Ins 3.8 f 0.V 3.1 rt 0.6 4.1 f 0.8*** 
Glu 7.0 IT 2.6 6.7 r 1.8 6.0 f 1.2 
Gln 1.8 f 1.6 1.5 t 1.3 2.2 2 1.6 
FWHMb 3.51 i 0.39 3.45 2 0.31 3.31 5 0.34 
a rnM refers to rnrnol/liter VOI. 
FWHM: full linewidth at half maximum (Hz) of the Cr signal at 3.03 pprn. 
*** p < 0.001, *’ p < 0.01, * p < 0.05 for comparisons to parietal white 
matter. 
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FIG. 3. Localized proton MR spectra of a 21 -year-old subject in 
frontal (1 2 ml), parietal (1 8 ml), and occipital gray matter (8 ml), as 
well as of a 25-year-old subject in the insular area (10 ml). Other 
parameters as in Fig. 2. 
Cerebellum and Thalamus 
Spectra from the cerebellar hemisphere and vermis are 
shown in the upper traces of Fig. 4. Although the VOI in 
the cerebellar hemisphere mainly contains white matter, 
its metabolite composition clearly differs from that of 
cortical white matter (e.g., compare Fig. 2). This is even 
better reflected in the absolute concentrations given in 
Table 3. Concentrations of Cr, Cho, and Ins are similar in 
both cerebellar areas but significantly higher than in any 
neocortical location. A prominent difference between the 
two cerebellar regions is the concentration of tNAA, 
which is significantly higher in the cerebellar hemi- 
spheres than in the central part. This is due to much 
higher amounts of NAAG in the hemispheres, whereas 
the NAA concentration in both areas is constant and 
slightly lower than in most cortical regions. Within the 
cerebellum no regional differences are observed for Glu 
and Gln. Whereas Glu levels are comparable to neocorti- 
cal regions, Gln concentrations resemble those in gray 
matter and are higher than in white matter. 
A representative spectrum of thalamus is shown in the 
bottom trace of Fig. 4. As a result of large variations in 
magnetic susceptibility that are mainly caused by a high 
iron load in adult tissues, spectra typically suffer from 
broad lines (i.e., a mean linewidth of 5.5 Hz as opposed 
to 3.5 Hz for most other brain regions at 2.0 T). Still, 
concentrations o f  major metabolites can be determined 
very reliably as demonstrated by standard deviations that 
are comparable to those in other brain areas. The main 
differences between gray matter in cortex and thalamus 
are the relatively high Cho and tNAA concentrations in 
the latter, whereas similar levels are found for Cr and Ins. 
A separate analysis of NAA and NAAG indicates the 
presence of high concentrations of NAAG in thalamus. 
Gender Effects and Hemispheric Asymmetry 
The intraindividual asymmetry parameters for Cr, tNAA, 
Cho, and myo-Ins are summarized in Table 4. For these 
metabolites no asymmetry is observed in any of the re- 
gions investigated bilaterally. In addition, 110 statistically 
significant interindividual asymmetry was detected by a 
t test of group averages of all right- and left-hemispheric 
spectra. 
The data base was further evaluated for gender differ- 
ences. Because these assessments were performed in ret- 
rospect, the measured spectra were not equally distrib- 
uted between the two sexes for all regions. However, 
using the data available, no statistically significant gen- 
der differences were obtained. The only exception was 
for Ins in parietal white matter where the ratio of female- 
to-male concentrations reached 1.3 ( p  < 0.01), i.e., 3.4 i- 
0.5 mA4for female (n = 14) and 2.6 i 0.4 mMfor male 
subjects (n = 6). 
DISCUSSION 
Apart from ignoring residual T,  and CSF corrections, the 
accuracy of an average concentration value as expressed 
by its standard deviation in Tables 1-3, reflects the mea- 
surement precision of individual spectra (depending on 
SNR and VOI size), the reliability of the evaluation pro- 
cess (characterized by LCModel estimates of individual 
concentration values), and true intersubject variability. 
For example, for relatively large gray matter volumes 
with high spectral SNR, evaluation by LCModel results 
in individual metabolite concentrations with experimen- 
tal uncertainties of only 3-7% for tNAA and Cr, and 
7-12% for Cho and Ins. The corresponding mean con- 
centrations averaged over all subjects exhibit larger stan- 
dard deviations of 6-12% for tNAA and Cr, 11-15% for 
Cho, and 15-21% for Ins (Table 2). This suggests that the 
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Table 2 









F W H M ~  
Frontal 
n = 12 
6.4 f 0.7 
8.4 i 1.0 
7.7 f- 1.0 
0.7 f 0.3 
4.3 i 0.9 
8.5 i 1.0 
4.4 i 1.4 
3.51 i 0.34 
1.38 f 0.1 7*** 
Parietal 
n = 19 
6.5 i 0.6 
8.7 2 0.8 
8.2 t 0.8 
0.5 ? 0.4 
1.10 i 0.14 
4.3 i 0.7 
8.2 i 1.1 
3.8 i 1.4 
3.50 f- 0.33 
Occipital 
n = 14 
6.9 t 0.7 
10.6 f 0.8*** 
9.2 i 0.9** 
1.4 f 0.8** 
0.88 f 0.10**' 
4.1 f 0.6 
8.6 f- 1.1 
3.9 f- 1.1 
4.06 t 0.31 
Insular 
n = 16 
7.0 5 0.6' 
9.6 t 0.6** 
8.7 f 0.8 
0.8 f 0.5* 
1.30 t 0.19** 
4.7 i 0.6 
8.8 i 0.8 
4.9 t 1.6' 
4.06 i 0.43 
a mM refers to mmol/liter VOI. 
FWHM: full linewidth at half maximum (Hz) of the Cr signal at 3.03 ppm. 
*** p < 0.001, ** p < 0.01, * p < 0.05 for comparisons to parietal gray matter 
interindividual variability due to small differences in 
VOI location and/or true physiologic differences is larger 
than the inaccuracy of the MRS quantification method. 
Similar arguments hold true for white matter, although 
smaller volumes and correspondingly lower SNR yield 
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FIG. 4. Localized proton MR spectra of a 25-year-old subject in 
the cerebellar hemisphere (8 mi), of a 25-year-old subject in the 
central cerebellum (8 ml), and of an 18-year-old subject in thala- 
mus  (6.4 ml). Other parameters as in Fig. 2. 
slightly larger experimental uncertainties for individual 
concentrations. 
It is also possible that the presence of intersubject 
variability precludes the detection of small differences 
between group averages of right and left hemispheres or 
between females and males. However, with the present 
accuracy (Table 4), our data do not support concepts of 
metabolic laterality previously hypothesized not only for 
the temporal lobe (20, 21),  but also for parietal and oc- 
cipital lobes (21). Pertinent reports are based on ratios of 
resonance intensities from long-echo time recordings 
without absolute quantification. Conversely, a long-echo 
time spectroscopic imaging study is in line with our 
finding of metabolic hemispheric symmetry (8). 
In general, the present work confirms the absence of a 
gender difference. This particularly applies to major me- 
tabolites such as tNAA and Cr with the best experimental 
accuracy. After ruling out that artifacts contribute to the 
exceptional result of a 1.3-fold higher Ins concentration 
in parietal white matter of female subjects, we fail to 
report an explanation. 
NAA and NAAG 
The finding of a heterogeneous distribution of tNAA in 
human brain is supported by studies in which no dis- 
tinction between NAA and NAAG has been made. The 
frontal to parieto-occipital increase of tNAA has been 
described (6, 71, as well as the generally higher tNAA 
concentration in white matter as compared to gray matter 
(3, 4, 8, 9). A relatively higher tNAA level in the cerebel- 
lar hemisphere as compared to the vermis has also been 
detected by spectroscopic imaging (22). 
Extending these observations by separating NAA and 
NAAG demonstrates that the significant differences in 
tNAA within and between different brain tissues are 
mainly due to a corresponding regional variation of 
NAAG. The distribution of NAA is rather homogeneous, 
with the exception of a slightly, but significantly higher 
concentration in occipital gray matter, i.e., in the func- 
tional area of the visual cortex. These findings parallel 
neuroanatomic reports of a constant neuronal cell den- 
sity in the neocortex except for a higher density exclu- 
sively in primary visual cortex (23, 24). It further sup- 
ports the use of NAA as a neuronal marker but also 
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Table 3 
Metabolite Concentrations in Cerebellum and Thalamus 
(mM t SD)" 
Cerebellum 
Thalamus 
Hemisphere Vermis n = 16 
n = 19 n = 8  
Cr 8.7 t 1.3 9.0 i 0.9 6.8 i 0.7 
t N A A  11 .O t 0.8 8.7 i 0.9*** 10.5 i 0.7 
NAA 7.4 i 1.0 7.4 2 0.8 7.3 i 1.3 
NAAG 3.6 t 0.9 1.3 i 0.8*** 3.2 t 1.1 
Cho 2.21 t 0.29 2.19 t 0.30 1.81 -c 0.21 
Ins 5.8 -C 1.1 5.6 t 1.1 3.6 2 0.9 
Glu 7.7 2 2.5 7.5 t 1.4 6.9 t 2.2 
Gln 4.3 2 2.5 5.4 t 2.2 2.9 ? 1.8 
FWHMb 5.03 t 0.74 3.72 t 0.47 5.48 t 0.69 
a mM refers to mmol/liter VOI. 
**I p i 0.001 for comparisons between both cerebellar regions. 
FWHM: full linewidth at half maximum (Hz) of the Cr signal at 3.03 ppm. 
precludes that this compound has a (metabolic) function 
that is specific for a certain cortical area. 
The concentration of NAAG varies from 0.5 mM in 
parietal gray matter to 3.6 mM in the cerebellar hemi- 
sphere. This distribution appears to be determined by 
both a general caudal increase proceeding from cerebrum 
to spinal cord (25) and a large difference in NAAG con- 
tent between gray and white matter. Because NAAG like 
NAA is a neuronal compound (25-27), it shares the ap- 
parent discrepancy to be highly concentrated not only in 
cell bodies (gray matter) but also in myelinated axons 
(white matter). A similar conclusion was drawn from an 
in vitro study of metabolites in rat brain, which showed 
high levels of NAA and especially NAAG in the adult 
optic nerve (28). An independent confirmation was given 
by immunohistochemistry demonstrating NAA and 
NAAG immunoreactivity in all parts of the nerve cells 
including dendrites, axons, and synaptic terminals (29). 
Whereas spectra from cortex and the cerebellar vermis 
show mean resonance linewidths of 3.3-4.1 Hz, the cer- 
ebellar hemispheres and thalamus result in mean lin- 
ewidths of 5.0-5.5 Hz (Tables 1-3). Although the accu- 
racy of LCModel depends on the magnetic field 
homogeneity and corresponding spectral resolution (30), 
the standard deviations for NAAG levels in these regions 
are similar to those in other regions. This suggests that 
the high NAAG concentrations found in thalamus and 
cerebellar hemisphere are reliable. It is further supported 
by the observation of correspondingly high NAAG levels 
in thalamus of young children where spectral resolution 
is excellent. Although cortical NAAG concentrations are 
Table 4 
lntraindividual Right-to-left Concentration Ratios (t SD) 
low at birth and increase only slowly, thalamus concen- 
trations are much higher (unpublished results). 
Total Creatine 
The concentration of Cr is rather constant within each 
tissue type, but increases significantly from cortical 
white matter (5.5-5.7 mM) to gray matter (6.4-7.0 mM) 
and cerebellum (8.7-9.0 mM). In thalamus the concen- 
tration (6.8 mM) is similar to that in cortical gray matter. 
Higher Cr levels in gray matter than in white matter have 
also been found in previous single-voxel MRS studies (3, 
4). In contrast, the usually much larger standard devia- 
tions for (relaxation-weighted) metabolite levels from 
spectroscopic imaging have precluded the observation of 
a statistically significant difference for Cr in white and 
gray matter (8,9). One study indicated higher Cr levels in 
gray matter when using image segmentation (10). Of 
course, this latter approach is applicable to metabolites 
with a homogeneous distribution within the same tissue 
type. For Cr it leads to similar results as obtained with 
single-voxel techniques. 
The high concentration of total creatine in the cerebel- 
lum is in  agreement with previous reports for both a 
hemispheric location (6) and the vermis (3, 8). In addi- 
tion, it corresponds to high amounts of cytosolic and 
mitochondria1 creatine kinase (CK) isoenzymes in this 
brain region (31, 32, and references therein). CK catalyzes 
the reversible phosphate transfer from PCr and ADP to Cr 
and ATP. Its cellular distribution reflects the heterogene- 
ity of brain ATP metabolism (33) .  High levels of CK in the 
granular layer of the cerebellum, which is rich in mito- 
chondria, are probably coupled to a high energy demand 
of synaptic and glial-neuron interactions in this region 
(31). Moreover, in chicken the cerebellum has been dem- 
onstrated as the only brain region with a muscle type CK, 
a finding that has tentatively been ascribed to the energy 
demands of the cerebellar Purkinje neurons (31). 
Choline-Containing Compounds 
Of all metabolites but NAAG, Cho shows the largest 
regional variability in the brain. Highly significant differ- 
ences are found between cortical gray and white matter, 
thalamus, and cerebellum with concentrations increas- 
ing in that order. Confirming previous studies using both 
single-voxel MRS (3, 4, 6) and spectroscopic imaging (8, 
g), cortical gray matter contains the lowest Cho concen- 
trations, whereas cerebellar levels are by a factor of 2-2.5 
higher. In addition to these differences between tissues, 
there exists a strong caudal gradient of decreasing Cho in 
Gray matter Cerebellum 
insular hemisphere 
n = 8  n = 8  
Thalamus 
n = 6  
Occipital 
n = 10 
White matter 
parietal 
n = 8  
Frontal 
n = 7" 
Cr 1.08 i 0.1 0 1.09 i 0.1 4 1.00 t 0.19 0.98 -C 0.1 1 1.01 t 0.19 1.01 ? 0.09 
tNAA 1.10 z 0.11 1.05 i 0.11 1 .OO t 0.04 1.01 2 0.11 1.03 2 0.09 1.02 2 0.09 
Cho 0.90 i 0.12 1.09 t 0.19 0.97 t 0.13 0.96 i 0.14 1.10 2 0.21 1.09 2 0.13 
1.19 2 0.31 Ins 1.02 i 0.37 1.11 t 0.19 1.04 i 0.21 1.03 ? 0.14 1.07 2 0.1 8 
a Number of subjects with bilateral spectral acquisitions. 
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cortical gray matter. This finding is in good qualitative 
agreement with a determination of choline-containing 
compounds in an autopsy study yielding 12.8, 10.5, and 
7.8 nmol/mg protein in frontal, parietal, and occipital 
human cortex, respectively (34). It is further in line with 
two recent spectroscopic imaging studies of elderly con- 
trols in which the intensity ratio of Cho/Cr resonances 
decreased ( 3 5 )  and that of NAAiCho increased (35, 36) 
from frontal to posterior paramedian gray matter. 
It may be argued that the observed Cho gradient in gray 
matter is partly due to different partial volume effects 
with white matter showing higher Cho concentrations. 
However, visual inspection of gray matter volumes 
shows that the VOIs contain only minor and similar 
portions of white matter. It is therefore more likely that 
the Cho distribution in gray matter as well as in other 
brain regions is correlated to regional differences in 
membrane lipid composition and metabolism. 
The main metabolites that contribute to the proton- 
detected Cho resonance in vivo are PCh and GPC. These 
compounds are involved in the metabolism of the mem- 
brane lipids phosphatidylcholine (i.e., lecithin) and cer- 
amidephosphocholine (i.e., sphingomyelin) (37, 38). Due 
to its high myelin content, white matter contains more 
lipids than gray matter (15.6% versus 5.9% of total wet 
weight) and also shows a different lipid composition. 
Under physiologic conditions both lecithin and sphingo- 
myelin are subject to continuous breakdown and resyn- 
thesis. Although glycerophospholipids are more stable in 
myelin than in other membranes with turnover rates 
between 1 week and 1 month (39), such rates also depend 
on the lipid side-chain composition which in turn exhib- 
its regional variations (37, 38). Because PCh and GPC are 
part of the metabolic pathway of lecithin and sphingo- 
myelin, the concentration of Cho and the content of the 
choline-containing phospholipids in a certain brain re- 
gion will be roughly correlated. However, they cannot be 
assumed to be directly proportional due to the many 
interfering variables. 
Myo-lnositol 
The concentration of Ins is lowest in white matter and 
thalamus, slightly higher in cortical gray matter (3, 4), 
and highest in both regions of the cerebellum. The latter 
observation also applies to Cr and Cho. Based on studies 
of cell type-specific cultures, Ins may be considered as a 
glial marker that is not present in neurons (40). Apart 
from its role in the metabolism of membrane-bound ino- 
sitol phospholipids and their links to a number of neu- 
ronal signaling systems, Ins mainly serves as an impor- 
tant brain osmolyte. 
Because Ins is involved in many biochemical pro- 
cesses, the reason for its heterogeneity in brain remains 
speculative. For example, the high levels of Ins (and Cho) 
in the cerebellum might be due to a higher glial and/or 
membrane density in this region. Alternatively, cerebel- 
lar osmoregulation may require high Ins levels as recent 
reports have mentioned an enhanced expression of the 
sodium myo-inositol cotransporter mRNA during hyper- 
natremia especially in cerebellum (41, 42). During 
changes in osmolality this cotransporter is involved in a 
redistribution of intracellular and extracellular Ins. 
Glutamate and Glutamine 
Both Glu and Gln show a relatively homogeneous distri- 
bution within single tissue types. In gray matter the ac- 
curacy of the observed concentrations is higher than in 
white matter due to larger VOI sizes and correspondingly 
higher SNR. Despite substantial overlap of spectral reso- 
nances, LCModel allows a reliable separation of Glu and 
Gln contributions at 2.0 T. This is underlined by the fact 
that for both Glu and Gln the difference between concen- 
trations in cortical gray matter (8.4 ? 1.0 and 4.0 2 1.3 
mM, respectively) and white matter (6.5 ? 1.9 and 1.9 +- 
1.5 mM, respectively) is highly significant ( p  < 0.0001). 
The present concentration values correlate well with a 
previous determination of total Glu and Gln of 12.5 
mmol/kg wet weight in gray matter and 8.1 mmol/kg in 
white matter (3). Qualitatively, a recent spectroscopic 
imaging study of Glu also indicated a higher level in gray 
matter than in white matter (43). Despite potential com- 
plications due to postmortem proteolysis, autopsy stud- 
ies yielded Glu concentrations of 7-10 mmol/kg for cor- 
tical and cerebellar gray matter and 4-5 mmol/kg for 
white matter, as well as Gln concentrations of 4-5 
mmol/kg for cortical gray matter with similar or higher 
levels in cerebellar cortex (44, and references therein). 
CONCLUDING REMARKS 
MRS strategies that optimize the experimental condi- 
tions for absolute quantification allow an objective and 
reproducible determination of metabolite concentrations 
within the human brain. In this context it is worth noting 
that single-voxel MRS features such as the ability to use 
long repetition times and the achievable spectral quality 
do not represent academic advantages, but are crucial in 
translating “spectral changes” into meaningful biochem- 
ical quantities. In particular, absolute metabolite concen- 
trations guarantee reliable intrasubject (e.g., follow-up 
studies) and intersubject comparisons (eg., patient ver- 
sus control). 
Extending previous observations this study unraveled 
detailed regional differences in cerebral metabolite pat- 
terns between as well as within tissue types. The data 
serve as base material for a variety of metabolic and 
functional brain studies and are already used as control 
for metabolic examinations of patients with brain disor- 
ders. 
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